Iambic Therapeutics Files for U.S. IPO, Adding Another AI Drug-Discovery Startup to Nasdaq Pipeline Sep 22, 2026 Life Science, Technology
Muse’s Rise Sparks Market Concerns, Financial, Insurance, and Travel Sectors Under Collective Pressure Sep 22, 2026 Technology
Nvidia’s Revenue Growth Far Outpaces Peers, Yet Its Valuation Remains Enticing Sep 22, 2026 Technology
U.S. Older Workers Are Exiting the Labor Force at an Accelerating Pace, and the AI Bull Market Is a Double-Edged Sword Sep 21, 2026 Technology
Meta Rallies 11% on Muse AI Agent as Wall Street Pivots to Application-Layer Thesis Sep 21, 2026 Technology
SMRs Poised for Takeoff as IAEA Triples Nuclear Outlook — Here Are the Stocks to Watch Sep 21, 2026 Energy
